Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
NCT01175226Phase 2Completed
- Sponsor
- Biota Holdings Limited
- Start
- Aug 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Vapendavir in human rhinovirus infection, sponsored by Biota Holdings Limited. Started Aug 2010; status: completed.
02
Drugs
Vapendavir
03
Conditions
human rhinovirus infection
Beyond the preview
Go deeper on NCT01175226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01175226.